Theravance Biopharma (TBPH) Net Margin Growth (5y) (2018 - 2026)
Theravance Biopharma (TBPH) Net Margin Growth (5y) (2018 - 2026) Analysis & Trends
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Theravance Biopharma | 864.82 Mn | 470.15 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -7,585.00 |
| Dec 31, 2025 | 46,413.00 |
| Sep 30, 2025 | 42,145.00 |
| Jun 30, 2025 | 62,836.00 |
| Mar 31, 2025 | 32,991.00 |
| Dec 31, 2024 | -5,545.00 |
| Sep 30, 2024 | 39,492.00 |
| Jun 30, 2024 | -4,217.00 |
| Mar 31, 2024 | 127,926.00 |
| Dec 31, 2023 | 28,847.00 |
| Sep 30, 2023 | 40,591.00 |
| Jun 30, 2023 | 6,008.00 |
| Mar 31, 2023 | 57,419.00 |
| Dec 31, 2022 | 195,190.00 |
| Sep 30, 2022 | 901,029.00 |
| Jun 30, 2022 | 205,538.00 |
| Mar 31, 2022 | 223,409.00 |
| Dec 31, 2021 | 135,543.00 |
| Sep 30, 2021 | 33,419.00 |
| Jun 30, 2021 | 41,125.00 |